- Home
- Supplements
- Saw Palmetto
- Prostate Cancer
Saw Palmetto for Prostate Cancer
Saw palmetto does not affect prostate cancer risk and failed to beat placebo for benign urinary symptoms in the STEP and CAMUS trials.
Overview
Verdict
Popular, extensively tested, and consistently negative.
How It Works
Dosing & Protocol
Typical dose
- Recommended dose
- No effective dose established
- Expected timeframe
- Not applicable.
Protocol
- form
- n/a
- notes
- Persistent urinary symptoms need medical evaluation
- duration
- n/a
- starting dose
- Not recommended
Evidence
What the studies say
No studies are yet linked to both Saw Palmetto and Prostate Cancer.
Safety
Caveats
Generally well tolerated; mild gastrointestinal upset. Rare reports of liver enzyme elevation. The real risk is delayed assessment of urinary symptoms.
Less likely to help if
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.